0.2867
Xtant Medical Holdings Inc stock is traded at $0.2867, with a volume of 97,515.
It is down -5.32% in the last 24 hours and down -10.41% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.3028
Open:
$0.3
24h Volume:
97,515
Relative Volume:
0.97
Market Cap:
$40.22M
Revenue:
$121.91M
Net Income/Loss:
$1.83M
P/E Ratio:
26.30
EPS:
0.0109
Net Cash Flow:
$7.75M
1W Performance:
-12.06%
1M Performance:
-10.41%
6M Performance:
-40.89%
1Y Performance:
-59.51%
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings Inc
|
0.2867 | 40.22M | 121.91M | 1.83M | 7.75M | 0.0109 |
|
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportBreadth Thrust - https://www.dars.gov.et/
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportPut Dominated - https://www.dars.gov.et/
Xtant Medical stock sits 66.32 percent below its 52-week high - AD HOC NEWS
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant Medical stock reports a second quarter revenue miss - AD HOC NEWS
Xtant Medical stock draws a USD 1.00 target from Lucid Capital - AD HOC NEWS
Xtant Medical Holdings, Inc. (XMS.SG) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
Xtant Medical stock trades quietly as investors weigh recent financial trends - AD HOC NEWS
Xtant Medical Holdings stock holds steady as investors eye latest results - AD HOC NEWS
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
Xtant Medical Holdings Inc. (XTNT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
XTNT stock focus shifts to latest medical device results and valuation - ad-hoc-news.de
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Canada
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Nigeria
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com UK
Lucid Capital initiates Xtant Medical stock with buy rating - Investing.com
Xtant Medical Holdings Inc. (XTNT) Peer Comparison – Compare with Others - Value Research
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Holdings Inc. (XTNT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - Sahm
XTNT SEC Filings, Jul-Aug 2025Xtant Medical Holdings, Inc. Filing Archive - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Canada
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - PR Newswire
Xtant Medical partners with BioHorizons for dental distribution - Investing.com
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - theglobeandmail.com
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com Nigeria
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - tradingview.com
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):